We are live on
!
Find out more
Viking Therapeutics
VKTX
VKTX
143 hedge funds and large institutions have $319M invested in Viking Therapeutics in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 45 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
46% more call options, than puts
Call options by funds: $16M | Put options by funds: $11M
14% more capital invested
Capital invested by funds: $280M → $319M (+$39M)
4% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 24
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 144 → 143 (-1)
1.32% less ownership
Funds ownership: 56.37% → 55.05% (-1.3%)
13% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 45
Holders
143
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
39
Reduced
45
Closed
24
Calls
$16M
Puts
$11M
Net Calls
+$5.01M
Net Calls Change
-$4.5M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.6M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$4.54M |
| 3 |
Jennison Associates
New York
|
-$3.19M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.88M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.83M |
